BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31554418)

  • 1. Variation in Coronary Atherosclerosis Severity Related to a Distinct LDL (Low-Density Lipoprotein) Profile: Findings From a Familial Hypercholesterolemia Pig Model.
    Hoogendoorn A; den Hoedt S; Hartman EMJ; Krabbendam-Peters I; Te Lintel Hekkert M; van der Zee L; van Gaalen K; Witberg KT; Dorst K; Ligthart JMR; Drouet L; Van der Heiden K; van Lennep JR; van der Steen AFW; Duncker DJ; Mulder MT; Wentzel JJ
    Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2338-2352. PubMed ID: 31554418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond early LDL cholesterol lowering to prevent coronary atherosclerosis in familial hypercholesterolaemia.
    Ibrahim S; Reeskamp LF; de Goeij JN; Hovingh GK; Planken RN; Bax WA; Min JK; Earls JP; Knaapen P; Wiegman A; Stroes ESG; Nurmohamed NS
    Eur J Prev Cardiol; 2024 May; 31(7):892-900. PubMed ID: 38243822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Human-Like Advanced Coronary Plaques in Low-Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques.
    Li Y; Fuchimoto D; Sudo M; Haruta H; Lin QF; Takayama T; Morita S; Nochi T; Suzuki S; Sembon S; Nakai M; Kojima M; Iwamoto M; Hashimoto M; Yoda S; Kunimoto S; Hiro T; Matsumoto T; Mitsumata M; Sugitani M; Saito S; Hirayama A; Onishi A
    J Am Heart Assoc; 2016 Apr; 5(4):e002779. PubMed ID: 27091180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Cholesterol Is Highly Associated with Severity of Hyperlipidemia and Atherosclerotic Lesions in Heterozygous LDLR-Deficient Hamsters.
    Wang J; He K; Yang C; Lin X; Zhang X; Wang Y; Liu G; Xian X
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31323736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid Biopsy of Extracellular Microvesicles Maps Coronary Calcification and Atherosclerotic Plaque in Asymptomatic Patients With Familial Hypercholesterolemia.
    Chiva-Blanch G; Padró T; Alonso R; Crespo J; Perez de Isla L; Mata P; Badimon L
    Arterioscler Thromb Vasc Biol; 2019 May; 39(5):945-955. PubMed ID: 30866660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in ultracentrifugally separated plasma lipoprotein subfractions in patients with polygenic hypercholesterolemia, familial combined hyperlipoproteinemia, and familial hypercholesterolemia after treatment with atorvastatin.
    Homma K; Homma Y; Yoshida T; Ozawa H; Shiina Y; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(2):210-6. PubMed ID: 25911077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.
    Vuorio A; Kovanen PT
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography.
    Tada H; Kawashiri MA; Okada H; Teramoto R; Konno T; Yoshimuta T; Sakata K; Nohara A; Inazu A; Kobayashi J; Mabuchi H; Yamagishi M; Hayashi K
    Am J Cardiol; 2015 Mar; 115(6):724-9. PubMed ID: 25618577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
    Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
    J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retardation of progression, stabilization, and regression of coronary and carotid atherosclerosis by low-density lipoprotein apheresis in patients with familial hypercholesterolemia.
    Koga N
    Ther Apher; 1997 Aug; 1(3):260-70. PubMed ID: 10225750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravascular ultrasound evaluation of coronary plaque regression by low density lipoprotein-apheresis in familial hypercholesterolemia: the Low Density Lipoprotein-Apheresis Coronary Morphology and Reserve Trial (LACMART).
    Matsuzaki M; Hiramori K; Imaizumi T; Kitabatake A; Hishida H; Nomura M; Fujii T; Sakuma I; Fukami K; Honda T; Ogawa H; Yamagishi M
    J Am Coll Cardiol; 2002 Jul; 40(2):220-7. PubMed ID: 12106923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia.
    Miname MH; Ribeiro MS; Parga Filho J; Avila LF; Bortolotto LA; Martinez LR; Rochitte CE; Santos RD
    Atherosclerosis; 2010 Dec; 213(2):486-91. PubMed ID: 20980000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long-Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events.
    D'Erasmo L; Minicocci I; Di Costanzo A; Pigna G; Commodari D; Ceci F; Montali A; Brancato F; Stanca I; Nicolucci A; Ascione A; Galea N; Carbone I; Francone M; Maranghi M; Arca M
    J Am Heart Assoc; 2021 May; 10(9):e018932. PubMed ID: 33890476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
    Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
    EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative burden in familial hypercholesterolemia.
    Mollazadeh H; Carbone F; Montecucco F; Pirro M; Sahebkar A
    J Cell Physiol; 2018 Aug; 233(8):5716-5725. PubMed ID: 29323716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of severe familial hypercholesterolemia in patients presenting for cardiac catheterization.
    Zafrir B; Shapira C; Lavie G; Halon DA; Flugelman MY
    J Clin Lipidol; 2016; 10(6):1338-1343. PubMed ID: 27919350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia.
    Neefjes LA; Ten Kate GJ; Alexia R; Nieman K; Galema-Boers AJ; Langendonk JG; Weustink AC; Mollet NR; Sijbrands EJ; Krestin GP; de Feyter PJ
    Atherosclerosis; 2011 Dec; 219(2):721-7. PubMed ID: 22018443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.